"五一"节后两个交易日，两家公募接连官宣自购旗下权益新基金。 5月7日，安信基金发布公告称，基于对中国资本市场长期健康稳定发展的信心，公司将出资不低于2000 万元，拟任基金经理及所在投资部门负责人将出资不低于500万元，合计共同出资不低于2500万元认购 安信优选价值混合，并承诺至少持有1年，最终认购申请确认金额以基金注册登记机构计算并确认的结 果为准。 安信优选价值混合是一只新基金，即将于5月12日开售，拟任基金经理为安信基金价值投资部副总经理 张明。他的代表作安信企业价值优选混合自2017年3月成立以来累计收益为1.2倍，年均复合增长率为 10.95%，远远跑赢沪深300指数。 值得一提的是，4月3日，安信基金也曾公告，公司于4月2日运用固有资金投资安信睿见优选混合1000万 元，并承诺至少持有1年，该基金成立于2023年4月，基金经理聂世林在基金发行期间已出资200万元认 购并持有至今。 富国基金"加仓"范妍 5月6日，富国基金同样发布公告称，公司及高管将出资不低于2000万元，拟任基金经理范妍将出资不低 于500万元，合计共同出资不低于2500万元认购富国均衡投资混合基金，并承诺至少持有1年，该基金 ...

Core Viewpoint - The recent self-purchase actions by public fund companies, such as FuGuo Fund and Morgan Fund, reflect confidence in their investment management capabilities and serve as a positive signal to investors [2][3][5]. Group 1: FuGuo Fund's Self-Purchase - FuGuo Fund announced a self-purchase of at least 25 million yuan for its balanced investment mixed securities fund, with contributions from the company and its senior management [3][4]. - The fund manager, Fan Yan, has a strong track record, with a return of 1.40% since October 2022 and a net asset value increase of 2.71% this year [4]. - The fund's scale increased significantly from 520 million yuan at the end of Q3 last year to 7.461 billion yuan at the end of Q1 this year, representing a growth of over 13 times [4]. Group 2: Morgan Fund's Self-Purchase - Morgan Fund plans to invest at least 54 million yuan in its newly launched equity public fund, with 30 million yuan allocated to the Morgan CSI A500 Enhanced Strategy ETF [5][6]. - The CSI A500 Enhanced Strategy ETF is designed to leverage a quantitative multi-factor model to select stocks, aiming for higher returns and better trading flexibility for investors [5]. - The total market size of passive index and enhanced index funds linked to the CSI A500 index reached 256.3 billion yuan as of March 31, 2025, indicating its growing importance in the A-share market [6]. Group 3: Overall Market Self-Purchase Trends - As of May 6, 2023, 114 fund companies have collectively purchased over 108 billion yuan in their own funds this year, surpassing the 100 billion yuan mark [7]. - The majority of self-purchases were in money market funds, totaling approximately 103.79 billion yuan, while equity funds saw self-purchases of 9.27 million yuan [8]. - The self-purchase actions by various fund companies, including Anxin and CCB Fund, demonstrate a commitment to market stability and a shared risk-reward approach with investors [8].

Group 1 - Yu Haichun has been appointed as the new chairman of Huafu Fund, succeeding Zhao Wanli who left due to work adjustments. Yu has 34 years of experience in the securities industry [1] - Morgan Fund announced an investment of no less than 54 million RMB in its newly launched equity public fund, demonstrating confidence in the long-term potential of the Chinese capital market [2] - Fangzheng Fubon Fund will invest 5 million RMB of its own funds in the Fangzheng Fubon CSI All Share Free Cash Flow ETF, also committing to hold for at least one year [2] Group 2 - As of March 2025, the total net asset value of public funds in China reached 32.22 trillion RMB, with 163 fund management institutions [3] - In March, various types of funds saw net subscriptions, with stock funds reaching 3.4 trillion shares, a 1.29% increase from the previous month [3] - QDII funds experienced the highest subscription activity in March, with a 3.57% increase in shares, totaling 562.68 billion shares [3] Group 3 - Over 70% of actively managed equity funds have increased their holdings in Hong Kong stocks, with a total market value increase of 98.25 billion RMB in the first quarter, reaching a three-year peak [4] - The average allocation to Hong Kong stocks among these funds rose to 25.79%, the highest level in five years [4] Group 4 - Wanminyuan has slightly reduced its holdings in Dongfang Biology, with the number of shares held decreasing from 4.71 million to 4.22 million in the first quarter of 2025 [5] - The fund managed by Wanminyuan is identified as the Rongtong Health Industry Fund [5] Group 5 - The Yi Nuo Si company has seen an increase in holdings by the Zhongou Medical Health Mixed Fund managed by Ge Lan, which now holds 403,100 shares, up from 99,500 shares at the end of the previous year [7] - Yi Nuo Si specializes in providing comprehensive R&D services for high-quality innovative drugs in the biopharmaceutical sector [7] Group 6 - On April 30, the market showed mixed performance, with the Shanghai Composite Index down 0.23% and the Shenzhen Component Index up 0.51% [8] - The total trading volume in the Shanghai and Shenzhen markets reached 1.17 trillion RMB, an increase of 147.2 billion RMB from the previous trading day [8] - AI-related ETFs in the Sci-Tech Innovation Board saw significant gains, while bank stocks collectively adjusted downwards [8]